Introduction
Phenolic compounds are commonly found in nature, particularly in plants, and they are known to be beneficial to human health because of their antibacterial, antitumor, anticancer, and anti-inflammatory effects, in addition to antioxidant activity [4, 17, 27, 35] . Therefore, many kinds of biologically active phenolic compounds such as catechin, resveratrol, quercetin, and rutin are used in food and cosmetics industries [2, 7] . However, phenolic compounds are limited in use as food and cosmetic materials since they have low water solubility and low light stability [15, 26] .
The enzymatic transglycosylation approach was reported as a general strategy to overcome the obstacles of phenolic compounds [11, 25, 30, 38] . Enzymatic reactions have several advantages over other chemical reactions, such as mild reaction conditions, eco-friendly nature, and specific glycosidic linkage formation [45, 48] . The transglycosylation activity of various carbohydrate-active enzymes has been used to modify many phenolic compounds, including genistin, resveratrol, catechin, and hydroquinone [11, 25, 30, 38] . The toxicity of glycosylated compounds was shown to be significantly lower than that of aglycone compounds [43] . There are several successful examples of transglycosylation [5, 12, 33, 38, 43, 45, 48] . Genistin, a functional isoflavone, was transglycosylated by 4-α-glucanotransferase to produce glycosyl-α-(1 → 4)-genistin and maltosyl-α-(1 → 4)-genistin, which have 3.7 × 10 3 and 4.4 × 10 4 times higher solubility than genistin, respectively [25] . Puerarin, a hypocholesterolemic antioxidant, was transglycosylated by maltogenic amylase to produce glucosyl-α-(1 → 6)-puerarin and maltosyl-α-(1 → 6)-puerarin. The solubility of puerarin glycoside was shown to be more than 100-fold greater than its unaltered form, and its antioxidant activity was fully maintained [12] . Ascorbic acid, a natural antioxidant, was transglycosylated by maltogenic amylase to produce maltosyl-α-(1 → 6)-ascorbic acid, which has better stability than ascorbic acid [5] .
Various carbohydrate-active enzymes such as glycosyltransferase and glycoside hydrolase have been applied to enzymatic synthesis of glycosylated compounds [6] . Glycosyltransferase has high transglycosylation activity by using activated glycosyl donors such as ADP-or UDP-glucose [6] . Nucleotideactivated sugars are natural substrates as glycosyl donors for highly selective synthesis; however, their industrial applications are limited owing to their high cost and low availability [18, 47] . Substrates catalyzed by glycoside hydrolase, such as sucrose and starch as glycosyl donors, are relatively inexpensive [18, 47] . Many glycoside hydrolases have been employed in enzymatic transglycosylation reactions [28, 42] . β-Glucosidases from bacterial or fungal origin possess significant transglycosylation activity in addition to hydrolytic properties. A fungal α-rhamnosyl-β-glucosidase from Acremonium sp. showed transglycosylation activity with broad acceptor specificity toward aliphatic and aromatic alcohols and the ability to synthesize the diglycoconjugated fluorogenic substrate 4-methylumbelliferylrutinoside [28] . Some hydrolytic enzymes in glycoside hydrolase (GH) family 13, including cyclodextrin glucanotransferase (CGTase), maltogenic amylase, maltodextrin glucosidase, and amylosucrase (ASase), were shown to have significant transglycosylation activity by forming an α-glycosidic linkage [42] .
Recently, the transglycosylation activity of ASase has received great attention since it utilizes a low-cost donor molecule, sucrose, and shows a broad range of acceptor specificity through various glycone and aglycone compounds. ASase has been found in relatively few microbial genomes such as Alteromonas macleodii, Archrobacter chlorohenlicus, Deinococcus geothermalis (DGAS), D. radiodurans (DRAS), Methylobacillus flagellates, and Neisseria polysaccharea [16, 20, 31, 32, 37, 39] . Among those, ASases from D. geothermalis (DGAS) and D. radiodurans (DRAS) showed different properties of thermostability, product ratios, and active-site topology properties, but their amino acid sequence homology is comparatively high [31, 39] . DRAS is relatively unstable compared with DGAS [31, 39] . Furthermore, the crystal structure of DRAS showed that subsite-1 of the active site, which was a deep pocket and was involved in transglycosylation of DRAS, was somewhat different from the corresponding site of DGAS [40] . The differences in the active-site pockets might explain why the elongation mechanism of ASase involves considerable conformational change that modulates accessibility to the sucrose binding site and then allows successive cycles of glucosyl-moiety transfer to a growing glucan chain [40] . Recently, Champion et al. [9] reported that loops 3, 4, and 7 of ASase contribute to the active-site topology properties; in particular, loop 4 plays a key role.
Recently, a homolog of ASase from the genome of D. radiopugnans (ATCC 19172), which is a mesophilic and highly radiation-resistant microorganism, has been identified [24] . The gene encoding ASase of D. radiopugnans (DRpAS) was expressed in Escherichia coli, and the recombinant DRpAS was characterized and its properties were compared with other varieties of ASase, especially with the two ASases from Deinococcus species [24] . In this study, the transglycosylation reaction of DRpAS was carried out using various phenolic compounds in order to investigate the acceptor specificity of DRpAS. Moreover, site-directed mutagenesis was performed to improve the acceptor specificity of DRpAS, and differences in the binding modes of DRpAS and its variants (DRpAS Q299K and DRpAS Q299R) were studied by in silico analysis.
Materials and Methods

Bacterial Strains and Chemicals
D. radiopugnans (ATCC 19172) was acquired from the Korea Atomic Energy Research Institute (Korea). E. coli strains were used for standard DNA manipulation and recombinant protein expression.
ΔlacX74 recA1 endA1 araD139 Δ(ara leu) 7697 galU galK rpsL nupG λ-] was used for DNA manipulations, and strain BL21(DE3) [F -dcm ompT hsdS(rB -mB -) gal λ(DE3)] was used for expression of recombinant proteins. Recombinant BL21 harboring pET-DRpAS, which encodes a putative ASase gene from D. radiopugnans, was previously constructed and reported by Kim et al. [24] . All chemicals were of reagent grade and were purchased from SigmaAldrich (USA) or Duchefa Biochemie B.V (The Netherlands). DNA restriction and modifying enzymes were obtained from New England Biolabs (USA). The α-glucosidase from yeast was purchase from Oriental Yeast Co. Ltd (Japan).
Site-Directed Mutagenesis of DRpAS
Site-directed mutagenesis was performed to construct DRpAS Q299R and DRpAS Q299K using the QuikChange II kit (Agilent Technologies, USA). pET-DRpAS [24] was used as template DNA for the site-directed mutagenesis. The design of each oligonucleotide primer (Q299R-F, Q299R-R, Q299K-F, and Q299K-R) for PCR amplification is shown in Table 1 . Amplification (94ºC for 1 min, 55ºC for 1 min, and 68ºC for 8 min) was executed using a thermal cycler. The amplified plasmids were digested with DpnI and transformed into E. coli DH10B cells. Clones were sequenced to verify the presence of the mutation and the absence of unwanted mutations. The verified mutated plasmids were reintroduced into E. coli BL21 (DE3) cells, and DRpAS Q299R and DRpAS Q299K proteins were expressed as described below.
Expression and Purification of Recombinant Proteins
Protein expression was induced by the addition of isopropyl-β- , 300 mM NaCl, and 10 mM imidazole, pH 7.0), and cells were disrupted by ultrasonication (output 4, six times for 30 sec, constant duty; Sonifier 450; Branson, USA). Finally, the recombinant protein in the cell lysate was purified using Ni-NTA affinity chromatography (Ni-NTA Superflow; Qiagen Inc., USA) [39] . The eluted protein was concentrated and dialyzed using a Vivaspin column (30,000 MWCO; Sartorius Stedim Biotech., GmbH, Germany) to remove imidazole, and the protein concentrations and enzymatic activity were measured prior to further study [39, 41] .
Analysis of Enzymatic Activity, Optimal pH and Temperature, and Thermostability
The enzymatic activities of DRpAS WT, DRpAS Q299R, and DRpAS Q299K were measured using the 3,5-dinitrosalicylic acid (DNS) method for detection of reducing sugars, where 1 unit of DRpAS WT, DRpAS Q299R, or DRpAS Q299K hydrolysis activity was defined as the amount of enzyme required to catalyze production of 1 μM of fructose per minute under the assay conditions [39, 41] . The effect of pH on the enzymatic activity of DRpAS WT, DRpAS Q299R, and DRpAS Q299K was investigated within the range of pH 4.0 to 10.0 at 40°C. The effect of temperature on the activity was studied between 25°C and 50°C at pH 8.0. The thermostability of purified DRpAS WT, DRpAS Q299R, and DRpAS Q299K was assessed by incubation of the enzyme in the absence of substrate at 40°C, 45°C, and 50°C. The residual enzymatic activity was measured under standard assay conditions at certain time intervals (5, 10, 15, 20 , and 25 min). Differential scanning fluorimetry (DSF; ABI 7500 Fast Real-Time PCR system; Applied Biosystems, Inc., USA), which has been used to measure the melting temperature (Tm) of protein, was performed using the procedures established by Jeong et al. [20] .
Thin-Layer Chromatography (TLC) Analysis
TLC was used to detect and to identify transglycosylation products after enzyme (DRpAS) reaction. The reaction products were spotted onto a Whatman K5F silica gel plate (Whatman, England) activated at 110°C for 30 min. One microliter of the reaction mixture was spotted onto a silica gel K5F plate and developed with a solvent system of isopropyl alcohol : ethyl acetate : water [3;1;1 (v/v/v)] in a TLC developing tank. Ascending development was performed once at room temperature. The plate was allowed to air-dry in a hood and was developed by soaking rapidly in 0.
in methanol. The plate was dried and placed in a 110°C oven for 10 min to visualize the reaction spots.
High-Performance Anion Exchange Chromatography (HPAEC) Analysis
HPAEC analysis was applied for carbohydrate detection using an analytical column. CarboPac PA1 (10 μm) and CarboPac PA200 (5.5 μm) columns (Dionex Co., USA) were used for analysis of small oligosaccharides and relatively long polysaccharides, respectively. Filtered samples (syringe filter, 0.45 μm; Whatman) were eluted using a linear gradient ranging from 100% buffer A (100 mM NaOH in water) to 60% buffer B (500 mM sodium acetate in buffer A) for 70 min. The flow rate of the mobile phase was maintained at 1.0 ml/min. Analytes were detected using a ED50 module (Dionex), and peak areas were calculated using the linear relationship between detector response per mole α-1,4-glucan chains and degree of polymerization, as reported by Pizzut-Serin et al. [31] .
Transglycosylation of Phenolic Compounds to Glycosyl Phenolic Compounds
The transglycosylation reaction of various phenolic compounds, including baicalin, cinnamic acid, ferulic acid, hesperidin, naringin, quercetin, and rutin, was performed in 10% (v/v) dimethyl sulfoxide (DMSO) in 50 mM sodium phosphate buffer (pH 8.0) at 40°C for 16 h. The reaction conditions for β-arbutin, salicin, and (+)-catechin were stated in previous reports [11, 22, 38] . Those reactions were performed without DMSO. The concentrations of various phenolic acceptors and related compounds were 10 mM, whereas 100 mM sucrose was used as a donor molecule. Reactions were performed with 2 units of enzyme (DRpAS or DGAS)/mg of sucrose.
High-Performance Liquid Chromatography (HPLC) and LC Tandem Mass Spectrometry (LC/MS/MS) Analysis
For HPLC analysis, reaction mixtures were centrifuged, filtered The codon of arginine: CGG.
The codon of lysine: AAG.
through a 0.2 μm Nylon 66 syringe filter (Whatman), and analyzed with a 4.6 × 250 mm, 5 μm Eclipse XDB C18 column (Agilent Technologies) connected to a Shimadzu model SCL-10 system with a Shimadzu LC10 pump and a Shimadzu SPD-10A UV detector (Shimadzu, Japan) at 350 nm. Separation of products was achieved using a 10-90% linear gradient with a mobile solvent of acetonitrile and water with 1% formic acid added, at a flow rate of 1.0 ml/min. All solvents were filtered, degassed, and kept under pressure. The confirmation of transglycosylation products was achieved by LC/MS/MS analysis. The reaction products were performed using an Agilent 6410B Triple Quadrupole mass spectrometer equipped with an electrospray ionization source (Agilent Technologies). The instrumental conditions were established in negative-ion mode, and peaks were monitored at 350 nm. Two types of eluents were used to separate the gradient: 0.1% formic acid in water (v/v) as solvent A, and 0.1% formic acid in acetonitrile (v/v) as solvent B. The injection volume was 1 μl, and elution was performed at a flow rate of 0.1 ml/min. Separation of products was achieved by a linear gradient from 100% solvent A/0% solvent B to 10% solvent A/90% solvent B for 15 min. Identification of the compounds was performed using a sampler (model G1377A), a binary pump (model G1312A), a column comp (model G1316A), and a diode array detector (model G1315D).
Identification of Transglycosylated Products by Enzymatic Hydrolysis
Transglycosylated products were identified by enzymatic hydrolysis with α-glucosidase. The transglycosylated mixture was further reacted with α-glucosidase in 50 mM potassium phosphate buffer (pH 6.8) at 37ºC for 1 h. The hydrolysis reaction mixture contained 100 μl of transglycosylated mixture and 2 μl of α-glucosidase solution.
Three-Dimensional Modeling and Molecular Dynamic Simulation of DRpAS
The three-dimensional structure of DRpAS was obtained from the automated comparative protein modeling server SWISSMODEL (http://swissmodel.exasy.org) [1, 23, 36] . The prediction of the DRpAS three-dimensional protein structure was based on the crystal structure of DGAS, which was previously determined (PDB code: 3UCQ). The protein pdb file and ligand (rutin) structures were obtained from the Brookhaven Protein Data Bank (PDB; http://www.rcsb.org) and the PubChem database (https:// pubchem.ncbi.nlm.nih.gov/), respectively. Molecular dynamic (MD) simulation was performed using the Gromacs 4.5.4 program [46] . GROMOS96 43a1 force-field parameters were used in the simulation. The initial model was derived from modeling the structure of DRpAS. The enzyme was solvated in a cubic box consisting of SPC216 water molecules and minimized energy in order to eliminate the high-energy intramolecular interactions. After energy minimization, 100 ps NVT (amount of substance, volume, and temperature are conserved) and NPT (amount of substance, pressure, and temperature are conserved) ensembles were used to equilibrate the system; the temperature and pressure conditions were constant at 300 K and 1 atm, respectively. Following the equilibration step, production of MD simulation was conducted for 20 nsec. Finally, analysis programs included in the GROMACS package were used to evaluate trajectories.
Prediction of DRpAS (Protein)-Rutin (Ligand) Interactions
The ligand molecule structure, rutin, was docked on the enzyme active site using AutoDock 4.2 software [29] . First, docking files were prepared according to the AutoDock4 requirements using AutoDock Tools 1.5.6, and all other parameters were kept at their default values [34] . All simulations used the hybrid Lamarckian Genetic Algorithm, with an initial population of 100 randomly placed individuals. Visualization of the three-dimensional structures and in silico mutagenesis of DRpAS was performed with PyMOL (http://www.pymol.org) [13] .
Results and Discussion
TLC Analysis of the Transglycosylation Reaction of DRpAS
The general enzymatic activity of recombinant DRpAS encoded by an ASase gene from D. radiopugnans (ATCC 19172) was studied previously 24]. The amino acid sequence of DRpAS showed strong homology to other ASases from the Deinococcus genus, DGAS and DRAS [24] . In order to examine the acceptor specificity of DRpAS, the transglycosylation reaction of DRpAS was employed with salicin, (+)-catechin, and β-arbutin as acceptor molecules, which were previously used in DGAS acceptor studies [11, 22, 38] . Transglycosylation products synthesized by DRpAS in the enzyme reaction mixture were analyzed by TLC (Fig. 1) . The transfer products from both β-arbutin and salicin as acceptors appeared with only one spot, respectively, whereas two transfer products were shown in (+)-catechin as an acceptor (Fig. 1) . The transglycosylation products of DGAS have been structurally determined previously [11, 22, 38] . Salicin and β-arbutin were transglycosylated to glycosyl-α-(1→4)-salicin and β-arbutin-α-glucoside, respectively [22, 38] . Moreover, (+)-catechin-3'-O-α-D-glucopyranoside and (+)-catechin-3'-O-α-Dmaltoside were synthesized from (+)-catechin [11] . When the R f values of each transglycosylation product of β-arbutin, (+)-catechin, and salicin synthesized by DRpAS (β-arbutin product: 0.77; (+)-catechin products: 0.87 and 0.82; and salicin product: 0.77) were compared with those by DGAS, they were analogous to each other (data not shown). Therefore, it was suggested that the acceptor specificities of DRpAS toward β-arbutin, (+)-catechin, and salicin were not significantly different from those of DGAS.
Rutin Is a Specific Acceptor of DRpAS
Transglycosylation reactions of DGAS [39] and DRpAS were performed with various phenolic acceptors and related compounds, including baicalin, cinnamic acid, ferulic acid, hesperidin, naringin, quercetin, and rutin. The transglycosylation reaction products were examined by HPLC in order to determine the available phenolic acceptors of DRpAS. Most compounds were poor acceptors for both DGAS and DRpAS (data not shown). However, rutin (quercetin-3-O-rutinoside) was effectively employed as an acceptor for the transglycosylation activity of DRpAS (Fig. 2) . The HPLC chromatogram revealed several reaction products in the DRpAS reaction compared with the DGAS reaction (Fig. 2) .
Confirmation of Transglycosylation Products Using α-Glucosidase and LC/MS/MS
When ASases are involved in transglycosylation reactions, they typically transfer glucoside molecule(s) from the donor compound (sucrose) to the acceptor molecules via α-1,4-glycosidic linkages [11, 22, 38] . The α-glucosidase (E.C. 3.2.1.20) acts on α-1,4-glycosidic linkages in many α-glucoside substrates to release glucose [10] . Therefore, the rutin reaction products created by DRpAS were hydrolyzed by α-glucosidase in order to confirm the presence of the rutin transglycosylation product. After the reaction of α-glucosidase, the main transglycosylation product peak (peak A) was dramatically decreased (Fig. 3) , indicating that this peak corresponds to the rutin transglycosylation product, and that DRpAS can use rutin as an acceptor molecule, whereas DGAS cannot. Moreover, DRpAS attached the glucoside residue to rutin through α-glucosidic linkages, as expected. Other peaks in the HPLC spectra might be minor rutin transglycosylation products, in which glucose molecules liberated from the donor were inefficiently attached to various -OH sites in rutin, indicating resistance to the α-glucosidase reaction.
The molecular mass of the transglycosylation product (peak A) was measured by tandem mass spectrometry (LC/MS/MS) analysis (Fig. 4) . The major peaks were at 771.1 m/z (Fig. 4A) and 609.0 m/z (Fig. 4B) in the MS/MS spectrum. These analytical results were in accordance with the expected m/z values of quercetin-3-O-rutinoside (rutin)-glucoside and quercetin-3-O-rutinoside (rutin), respectively. This result combined with the results of our enzymatic analysis implies that the chemical structure of the major rutin transglycosylation product was glycosyl-α-(1→4)-rutin.
Analysis of DRpAS 3D Structure by Molecular Dynamics Simulation for Modulation of Transglycosylation Activity
Rutin has been used as an acceptor by DRpAS, but not by DGAS. Since both enzymes have a strong amino acid sequence homology, possible differences in active-site moieties were examined by using MD simulation. Since the 3D structure of DGAS has been determined, the 3D structure of DRpAS could be predicted from computer simulation studies [1, 13, 23, 29, 34, 36, 46] . Hence, the model structure of DRpAS was obtained by SWISSMODEL (http://swissmodel.exasy.org) using the DGAS structure (PDB code: 3UCQ) as a template [1, 23, 36] . The structure of DRpAS was subjected to MD simulation (20 nsec) in explicit water under constant temperature and pressure conditions. The root-mean-square deviation (RMSD) of the atomic positions with respect to the starting structure was calculated. The RMSD of DRpAS atoms increased to 2.5 Å before 10 nsec and was maintained at that level until 20 nsec (data not shown). This result indicates that the DRpAS 3D structure reached an equilibrium state after an initial increase of DRpAS atom fluctuation.
Analysis of Amino Acid Residues for Improvement of Transglycosylation Activity of DRpAS
The finding of amino acid residues that influence acceptor binding in the transglycosylation reactions of DRpAS was challenging. Previous studies have shown that loop 3, loop 4, and loop 7 contribute to the active-site topology in ASase [8, 9] . These loops are considerably flexible and are associated with the active-site structure; in particular, loop 4 plays a key role [8, 9] . In this study, amino acid sequence alignment revealed that the amino acid sequences in loop 4 of DGAS and DRAS were similar to those in loop 4 of DRpAS, with the exception of two amino acids (Ser297 and Ser298 in DRpAS) [24] . The two differing residues in loop 4 might influence acceptor binding in the transglycosylation reactions of DRpAS. MD simulation was applied for flexibility of individual amino acid residues [3, 19] , and it suggested an interaction between Ser297 and Gln299 in DRpAS, indicating that this interaction might cause a more rigid conformation of loop 4 (Fig. 5A) . Therefore, it was predicted that the intermolecular interaction of loop 4 would be more flexible if the Gln299 residue in loop 4 of DRpAS was substituted with a different amino acid residue. The longer amino acids such as lysine or arginine might be effective to modulate the flexibility of loop 4 in DRpAS (Figs. 5B and 5C), which may change the transglycosylation activity performance of DRpAS.
Construction of DRpAS Variants and Comparison of Their Transglycosylation Activity
We investigated the hypothesis that substitution of Gln299 would improve the acceptor specificity of DRpAS, by creating DRpAS variants and comparing their activity with that of WT DRpAS. Mutant enzymes DRpAS Q299K and DRpAS Q299R were constructed using site-directed mutagenesis. The single-point mutated genes were successfully amplified (pETDRpAS Q299K and pETDRpAS Q299R) and expressed in E. coli BL21 (DE3). Fortunately, the recombinant enzymes were active and easily purified by Ni-NTA affinity chromatography (data not shown).
The acceptor specificities of the two mutants (DRpAS Q299K and DRpAS Q299R) and the WT enzyme were compared through reaction with sucrose and rutin. The reaction mixtures were analyzed by HPLC (Fig. 6) . The result of the HPLC analysis revealed that DRpAS Q299K and DRpAS Q299R produced higher levels of transglycosylation products than did the WT. In particular, DRpAS Q299K generated a 10-fold increase in transglycosylation products compared with the WT, whereas DRpAS Q299R showed a 4-fold increase in product compared with the WT (Fig. 6) . These results were consistent with previous findings that double mutants at the rim of the substrate pocket on ASase from Neisseria polysaccharea (NPAS) altered the flexibility that controls active-site topology, especially loops 3, 4, and 7 [8, 9] . In this study, when the Gln299 located in loop 4 of DRpAS was replaced by lysine or arginine, which have a longer side chain, a weaker interaction between Lys299/ Arg299 and Ser297 was developed. As a result, the flexibility of loop 4 might be increased and resulted in an improved accessibility of the acceptor molecule (rutin) in the catalytic site. As a result, the transglycosylation of rutin was more efficiently carried out in mutant DRpAS. A number of studies have reported similar findings where the flexible loop of protein controlled both enzymatic activity and specificity [14, 21, 44] .
Comparison of Loop 4 Conformation Via Molecular Docking Analysis
To confirm differences in binding modes among the variants, molecular docking was performed to analyze the active-site topology of variants in complex with the glucosyl moiety and rutin as a ligand. Individual DRpAS variants (DRpAS, DRpAS Q299K, and DRpAS Q299R) were obtained after in silico mutagenesis using PyMOL [13] . Then, AutoDock analysis was employed to determine the best binding model (Fig. 7) [29] . The DRpAS-glucose intermediate model of DRpAS with glucosyl moiety showed that catalytic residues (327E, 255D) interacted with glucose (Fig. 7A) . The molecular docking of these variants with rutin showed that loop 4 interacted with rutin (Figs. 7B-7D ). According to the molecular docking of DRpAS, DRpAS Q299R, and DRpAS Q299K, the quercetin-moiety of rutin is located inside the binding site (Figs. 7B-7D ). Arginine and lysine at position 299 led to the creation of a closed active pocket compared with glutamine, which increased binding of rutin (Figs. 7B-7D ). The introduction of an arginine or lysine residue (DRpAS Q299R and DRpAS Q299K) at position 299 led to a drastic increase in transglycosylation activity for rutin as an acceptor compared with DRpAS (Fig. 6 ). In particular, the lysine residue at position 299 in DRpAS Q299K may enable rutin to more easily position itself inside the active pocket than in the WT owing to a conformational change of loop 4 (Figs. 7B and 7D) . As a result, the conformational change in the active pocket caused by substitution of an amino acid (Q299R and Q299K), which affected the intermolecular interactions between loop 4 and other residues, modulates the acceptor specificity and enhances the production of rutin derivatives. In conclusion, DRpAS variants (DRpAS Q299R and DRpAS Q299K) can be used as a powerful enzymatic tool to synthesize rutin glucosides and other phenolic compounds.
